知镜 Cognispect · 医学文献与研究工作台

Diagnostic yield of genome sequencing for children with intellectual disability and developmental delay.

Rigobello R, Driver M, Robak LA, Scott DA, Vossaert L, Chibuk J, Meng L, Xia F, Eng CM, Giannikopoulos P, Zhao X.
Frontiers in neurology · 2026-09-24 · PMID 42851323

文献摘要

Background Genome sequencing (GS) has recently been considered as a first-tier diagnostic tool for individuals with intellectual disability (ID) and developmental delay (DD). In this study, we assess the diagnostic yield of GS for a large cohort of children with ID/DD and describe variants contributing to genetic diagnoses in this cohort. Methods A retrospective analysis of consecutive GS results for individuals under 18 years of age with a clinical indication of ID/DD was conducted using data from a clinical diagnostic laboratory. The present analysis included 666 individuals. Results In this cohort, 31.1% (207/666) of children received positive GS results. There were 186 children who received a genetic diagnosis that was at least partially associated with their history of ID/DD, leading to a phenotype-specific diagnostic yield of GS for ID/DD of 27.9%. For individuals without known prior genetic testing, 35.3% (103/292) had positive GS results. There were 259 variants that led to genetic diagnoses in this cohort. Of these, 7.7% (20/259) were variants with limited to no coverage on exome sequencing. Conclusion GS identified at least one genetic diagnosis associated with ID/DD in 27.9% of children with ID/DD as a clinical indication. An additional 3.2% of children received positive GS results associated with other features of their clinical indication. Almost 8% of variants related to the genetic diagnoses in this cohort may not have been detected through other standalone genomic technologies. These findings further support the recommendation by medical and professional societies of GS as a first-tier diagnostic test for individuals with ID/DD.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。